Abstract:We examined the neurocirculatory and ventilatory responses to intermittent asphyxia (arterial O(2) saturation = 79-85%, end-tidal PCO(2) =3-5 Torr above eupnea) in seven healthy humans during wakefulness. The intermittent asphyxia intervention consisted of 20-s asphyxic exposures alternating with 40-s periods of room-air breathing for a total of 20 min. Minute ventilation increased during the intermittent asphyxia period (14.2 +/- 2.0 l/min in the final 5 min of asphyxia vs. 7.5 +/- 0.4 l/min in baseline) but … Show more
“…Six groups of subjects were examined in the study: (1) healthy controls, (2) patients with AH alone, (3,4,5) those with mild, moderate and severe SAHS, and (6) those with SAHS treated by CPAP. The study was designed to determine the secondary hypertensive effect of SAHS and the BP-lowering effect of CPAP therapy by comparisons of approximately 30 variables obtained during parallel ABPM and whole-night polysomnography, with the informed consent of all subjects.…”
Section: Subjects and Protocolmentioning
confidence: 99%
“…Hypoxemia and hypercapnia resulting mainly from apneahypopnea episodes initiate progressive activation of the sympathetic nervous system, involving the carotid sinus and aortal baroreceptors [3,4,6,34,35]. Arousal reactions induced by repeated apnea episodes also provoke sympatho-adrenergic activation, despite interruption of hypoxic-hypercapnic stimuli, and they could lead to the elevation of heart rate and BP [3,4]. In addition, the upper-airway stimulation induced by pressure changes caused by snoring, or post-apnea sighs and gasps may evoke reflex tachycardia and vasoconstriction already present in the early stages of SAHS.…”
Section: 1mentioning
confidence: 99%
“…Sleepdisordered breathing has been found to occur in 24% of men and 9% of women in the general population [1,2]. Frequent apnea-hypopnea episodes in patients with SAHS trigger various hemodynamic effects that are in direct contrast to the relaxation effects of physiological sleep; these include arterial hypertension (AH) resulting from hypoxia, hypercapnia, arousal, and sympathetic stimulation [3][4][5][6][7]. Several studies have established that patients with SAHS have a higher prevalence of AH than the general population, even after adjusting for such confounding variables as body mass index, age, and sex [5,[8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Previously unrecognized AH has also been found by clinical BP measurement in 39% of patients with newly diagnosed SAHS and by ambulatory blood pressure monitoring (ABPM) in as many as 62% [13,14]. SAHS is also an independent risk factor for AH and various cardiovascular diseases, such as coronary artery disease, myocardial infarction, stroke, and atherosclerosis [2,4,10,[15][16][17][18][19][20][21].…”
AbstractAmbulatory blood pressure monitoring and parallel polysomnographic study were performed in 116 adult males divided into 6 groups. Thirty blood-pressure (BP) and polysomnographic variables were measured to test their usefulness for screening for both arterial hypertension and sleep apnea-hypopnea syndrome (SAHS). The development of severe breathing disorders and hypoxemia during sleep was attributed to SAHS, when compared with measurements in healthy controls and in patients with arterial hypertension. Such disorders manifested as an increased apnea-hypopnea index, apnea index, duration of arterial oxygen saturation of less than 85%, and decrease of average arterial oxygen saturation that correlated with nocturnal average diastolic BP (p=0.0049, p=0.0027, p=0.049 and p=0.0457, respectively). These respiratory disorders resulted in various nocturnal, rather than diurnal, and diastolic and systolic BP variables. The acute antihypertensive effect of continuous positive airway pressure therapy for SAHS significantly reduced the episodes of apnea and hypopnea and the secondary component of hypertension caused by excessive sympathetic stimulation. For the SAHS-induced, dose-dependent component of hypertension that responded to continuous positive airway pressure, the following variables, in decreasing significance, were useful: nocturnal average systolic and diastolic BP and 24-hour average systolic and diastolic BP, as well as percent time elevation and mean blood pressure load. The monitoring of these variables could contribute to early diagnostic and prognostic stratification of complications and adequate therapy of the secondary component of hypertension caused by SAHS.
“…Six groups of subjects were examined in the study: (1) healthy controls, (2) patients with AH alone, (3,4,5) those with mild, moderate and severe SAHS, and (6) those with SAHS treated by CPAP. The study was designed to determine the secondary hypertensive effect of SAHS and the BP-lowering effect of CPAP therapy by comparisons of approximately 30 variables obtained during parallel ABPM and whole-night polysomnography, with the informed consent of all subjects.…”
Section: Subjects and Protocolmentioning
confidence: 99%
“…Hypoxemia and hypercapnia resulting mainly from apneahypopnea episodes initiate progressive activation of the sympathetic nervous system, involving the carotid sinus and aortal baroreceptors [3,4,6,34,35]. Arousal reactions induced by repeated apnea episodes also provoke sympatho-adrenergic activation, despite interruption of hypoxic-hypercapnic stimuli, and they could lead to the elevation of heart rate and BP [3,4]. In addition, the upper-airway stimulation induced by pressure changes caused by snoring, or post-apnea sighs and gasps may evoke reflex tachycardia and vasoconstriction already present in the early stages of SAHS.…”
Section: 1mentioning
confidence: 99%
“…Sleepdisordered breathing has been found to occur in 24% of men and 9% of women in the general population [1,2]. Frequent apnea-hypopnea episodes in patients with SAHS trigger various hemodynamic effects that are in direct contrast to the relaxation effects of physiological sleep; these include arterial hypertension (AH) resulting from hypoxia, hypercapnia, arousal, and sympathetic stimulation [3][4][5][6][7]. Several studies have established that patients with SAHS have a higher prevalence of AH than the general population, even after adjusting for such confounding variables as body mass index, age, and sex [5,[8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Previously unrecognized AH has also been found by clinical BP measurement in 39% of patients with newly diagnosed SAHS and by ambulatory blood pressure monitoring (ABPM) in as many as 62% [13,14]. SAHS is also an independent risk factor for AH and various cardiovascular diseases, such as coronary artery disease, myocardial infarction, stroke, and atherosclerosis [2,4,10,[15][16][17][18][19][20][21].…”
AbstractAmbulatory blood pressure monitoring and parallel polysomnographic study were performed in 116 adult males divided into 6 groups. Thirty blood-pressure (BP) and polysomnographic variables were measured to test their usefulness for screening for both arterial hypertension and sleep apnea-hypopnea syndrome (SAHS). The development of severe breathing disorders and hypoxemia during sleep was attributed to SAHS, when compared with measurements in healthy controls and in patients with arterial hypertension. Such disorders manifested as an increased apnea-hypopnea index, apnea index, duration of arterial oxygen saturation of less than 85%, and decrease of average arterial oxygen saturation that correlated with nocturnal average diastolic BP (p=0.0049, p=0.0027, p=0.049 and p=0.0457, respectively). These respiratory disorders resulted in various nocturnal, rather than diurnal, and diastolic and systolic BP variables. The acute antihypertensive effect of continuous positive airway pressure therapy for SAHS significantly reduced the episodes of apnea and hypopnea and the secondary component of hypertension caused by excessive sympathetic stimulation. For the SAHS-induced, dose-dependent component of hypertension that responded to continuous positive airway pressure, the following variables, in decreasing significance, were useful: nocturnal average systolic and diastolic BP and 24-hour average systolic and diastolic BP, as well as percent time elevation and mean blood pressure load. The monitoring of these variables could contribute to early diagnostic and prognostic stratification of complications and adequate therapy of the secondary component of hypertension caused by SAHS.
“…In a study by XIE et al [43], a hypercapnic hypoxic gas mixture was administered intermittently (20 s of the gas mixture, 40 s normoxia) in healthy subjects during 20 min. Muscle SNA was found to follow a cyclic crescendo-decrescendo pattern in conjunction with asphyxic periods.…”
Section: The Mechanisms Underlying Ht/vd In Osa: What Is Known So Far?mentioning
the participants of working group 2 " ABSTRACT: The objective of the present article was to explore the relationship between obstructive sleep apnoea (OSA) and hypertension (HT) and/or arterial vascular disease (VD), including stroke and ischaemic coronary disease.Epidemiological and interventional studies on these relationships provide compelling evidence that OSA is causally related to HT. The causal relationship between OSA and VD other than HT has not been firmly established.A number of pathophysiological mechanisms that could potentially provide a causal link between obstructive sleep apnoea and hypertension, as well as vascular disease, have been identified. Available data on such mechanisms include sustained daytime sympathetic activation, oxidative stress, promotion of vascular inflammation and endothelial dysfunction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.